Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, 6 Święcickiego St., 60-781 Poznan, Poland.
Rheumatol Int. 2013 May;33(5):1121-5. doi: 10.1007/s00296-012-2509-y. Epub 2012 Sep 5.
There are several studies on the association of TLR9 polymorphisms with systemic lupus erythematosus (SLE) in different ethnicities; however, the results are inconsistent. Therefore, we studied the distribution of the TLR9 C > T (rs352140) polymorphism in patients with SLE (n = 254) and controls (n = 521) in a Polish population. We did not observe significant differences in the prevalence of the TLR9 C > T genotype and alleles between patients with SLE and controls. However, we found a contribution of the T/T and T/C genotypes to renal [OR = 2.949 (95 % CI = 1.523-5.711, p = 0.001), (p corr = 0.017)] and immunologic disorders [OR = 2.938 (95 % CI 1.500-5.755, p = 0.0012), (p corr = 0.0204)] in SLE patients. Moreover, we observed a significant association between the TLR9 T/T and T/C genotypes and the presence of anti-dsDNA Ab [OR = 3.682 (1.647-8.230, p = 0.001), (p corr = 0.017)]. Our studies suggest that the TLR9 C > T (rs352140) polymorphism might contribute to renal and immunologic disorders and to the presence of anti-dsDNA Ab.
有几项关于 TLR9 多态性与系统性红斑狼疮(SLE)在不同种族中的关联的研究;然而,结果并不一致。因此,我们研究了 TLR9 C>T(rs352140)多态性在波兰人群中 SLE 患者(n=254)和对照组(n=521)中的分布。我们没有观察到 SLE 患者和对照组之间 TLR9 C>T 基因型和等位基因的患病率存在显著差异。然而,我们发现 T/T 和 T/C 基因型与肾脏[OR=2.949(95%CI=1.523-5.711,p=0.001),(p corr=0.017)]和免疫紊乱[OR=2.938(95%CI 1.500-5.755,p=0.0012),(p corr=0.0204)]有关。此外,我们还观察到 TLR9 T/T 和 T/C 基因型与抗 dsDNA Ab 的存在之间存在显著关联[OR=3.682(1.647-8.230,p=0.001),(p corr=0.017)]。我们的研究表明,TLR9 C>T(rs352140)多态性可能与肾脏和免疫紊乱以及抗 dsDNA Ab 的存在有关。